Health Dictionary Find a Doctor

Encephalopathy


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Encephalopathy is a clinical manifestation that can be caused by any pathology affecting brain function. The pathology can be intracranial or extra-cranial in origin. This brain malfunction can be due to systemic metabolic derangements in cardiopulmonary,mitochondrial[[3]], renal, hepatic or endocrine systems. In medical jargon it can refer to a wide variety of degenerative brain disorders with very different etiologies, prognoses and implications. For example, prion diseases, all of which cause transmissible spongiform encephalopathies, are nearly always fatal and have an infectious origin, but other encephalopathies are reversible and can be caused by deficiency, toxins, and several other causes.

References


Classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Encephalopathy can be classified based upon the underlying pathophysiology.

Classification

There are many types of encephalopathy.

References


Template:WH Template:WS

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Encephalopathy may be due to damage to blood brain barrier with accumulation of toxic substances (Hepatic encephalopathy), low oxygen (Hypoxic encephalopathy), low levels of vitamins such as vitamin B1 (Wernicke encephalopathy) and sepsis (Septic encephalopathy).

Pathophysiology

Encephalopathy is a broad term given to numerous condition’s which cause dysfunction of the brain. There are various underlying mechanisms:

The brain is protected from the circulatory toxins by the blood brain barrier lined by astrocytes. In cases of hepatic failure due to any reason, the detoxifying capacity of liver is drastically reduced. This causes an increase in the concentration of circulatory toxins like ammonia, mercaptans, manganese. Circulatory toxins damage the barrier made by astrocytes and cause pathological changes in the cells. This alters blood brain barrier and toxins gain access into the brain tissues.

The brain needs a large oxygen supply owing to its high metabolic activity. When oxygen is deprived from the brain, energy stores of the neuronal cells is decreased rapidly resulting in neuronal injury and encephalopathy.

Normal neuronal activity requires a balanced environment of electrolytes, water and lots of substrates. In case of dehydration and renal diseases causing electrolyte abnormalities this equilibrium is disturbed. This results in dysfunction of the brain.

This is a disorder of diencephalic brain tissue around the third and fourth ventricle. It results of deficiency of vitamin B1, thiamine. It is the most under recognized cause of encephalopathy in intensive care units. Thiamine is an important co-factor for enzyme required for glucose utilization in brain. If this is deficient it automatically goes into a low energy state and performs suboptimally.

Sepsis elicits a systemic inflammatory response which produces numerous cytokines and other micro circulatory abnormalities. These damage the blood brain barrier and damage the brain tissue.

References

Template:WH

Template:WS

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Encephalopathy alters brain function and/or structure. It may be caused by an infectious agent (bacteria, virus, orprion), metabolic or mitochondrial dysfunction, brain tumor or increased intracranial pressure, prolonged exposure to toxins (including solvents, drugs, alcohol, paints, industrial chemicals, and certain metals), radiation, chronic progressive trauma, poor nutrition, or lack of oxygen or blood flow to the brain. It is also known that concomitant use of lithium with other neuroleptics may, in rare cases, cause encephalopathy.

Causes

Common Causes

Causes by Organ System

Cardiovascular Hemorrhagic shock, Malignant hypertension, Progressive encephalopathy with edema, hypsarrhythmia and optic atrophy
Chemical / poisoning Alcohol withdrawal, Aluminum , Carbon monoxide poisoning, Ifosamide, Lead poisoning, Methylene Chloride , Narcotics, Occupational lead exposure , Toxic mushrooms
Dermatologic No underlying causes
Drug Side Effect Aldesleukin, Aminosalicylic acid, Blinatumomab, Bortezomib, Cefepime, Ceftazidime, Ciclosporin, Cidofovir, Cisplatin, Cysteamine , Cytarabine, Cytarabine liposome, Epoetin beta , Esomeprazole, Gallium nitrate, Gentamicin, Imipenem-Cilastatin, Levofloxacin , Melarsoprol, Metronidazole, Muromonab-CD3, Nitisinone, Ramucirumab, Topiramate, Valacyclovir, Valproate, Zanamivir, Zonisamide
Ear Nose Throat No underlying causes
Endocrine Hashimoto’s encephalopathy
Environmental Hypoxia, Near drowning
Gastroenterologic Acute liver failure , Budd-Chiari syndrome , Chronic liver disease , Cirrhosis of liver , Idiopathic liver cirrhosis , Liver failure, Obliterative portal venopathy , Reye syndrome , Spontaneous bacterial peritonitis, Wernicke-Korsakoff syndrome , Hepatoma
Genetic Chromosome 18 Ring, Pyridoxamine 5-prime-phosphate oxidase deficiency , Chromosome 9, trisomy 9q, Chromosome 9q duplication syndrome, Bonnemann-Meinecke-Reich syndrome , Landau–Kleffner syndrome , Lennox–Gastaut syndrome, Ohtahara syndrome , West syndrome, Carnitine deficiency syndromes , Carnitine palmitoyl transferase deficiency , Carnitine transporter deficiency , Cytochrome c oxidase deficiency , MELAS , NADH CoQ reductase deficiency
Hematologic Mosse syndrome
Iatrogenic Peritoneal dialysis, Transjugular intrahepatic porto systemic shunt
Infectious Disease Adenoviridae Infections , Boutonneuse fever , Bovine spongiform encephalopathy , Brain abscess, HIV, India tick typhus , Israeli spotted fever , Kuru, Lyme disease , Marseilles fever , Mediterranean Spotted Fever , Psittacosis , Whooping Cough , Spontaneous bacterial peritonitis, Guillain-Barre syndrome
Musculoskeletal / Ortho Neuromuscular disorder
Neurologic Bing-Neel syndrome , Bonnemann-Meinecke-Reich syndrome , Early myoclonic encephalopathy, Granulomatous angiitis, Guillain-Barre syndrome, Landau–Kleffner syndrome , Lennox–Gastaut syndrome, Motor neuron disease, Myasthenia gravis, Neuromuscular disorder, Ohtahara syndrome , Progressive encephalopathy with edema, hypsarrhythmia and optic atrophy, Post-ictal state, Raised intracranial pressure, Scrapie, Stroke, West syndrome, Bovine spongiform encephalopathy , Aicardi-Goutieres syndrome
Nutritional / Metabolic Acidosis, Alcoholism, Carnitine deficiency syndromes , Carnitine palmitoyl transferase deficiency , Carnitine transporter deficiency , Coenzyme Q 10 deficiency , Complex 1 mitochondrial respiratory chain deficiency , Cytochrome c oxidase deficiency , Electrolyte abnormalities, HMG CoA synthetase deficiency , Hyperammonemia, Hypoglycemia, Inborn urea cycle disorder , Malnutrition, MELAS , NADH CoQ reductase deficiency , Obesity, Ornithine transcarbamylase (OTC) Deficiency , Thiamine deficiency, Uremia, Uremic encephalopathy, Vitamin B deficiency, Wernicke Korsakoff syndrome , Wernicke’s encephalopathy, Pyridoxamine 5-prime-phosphate oxidase deficiency
Obstetric/Gynecologic Acute fatty liver of pregnancy
Oncologic Brain tumour, Hepatoma
Opthalmologic No underlying causes
Overdose / Toxicity Acetaminophen toxicity
Psychiatric No underlying causes
Pulmonary Asthma, Atelectasis, Bronchiectasis, Central alveolar hypoventilation, Chronic obstructive pulmonary disease, Ephysema, Obesity hypoventilation syndrome, Pneumonia, Pneumothorax, Primary alveolar hypoventilation, Sleep apnea
Renal / Electrolyte Hyponatremia, Renal failure
Rheum / Immune / Allergy Aicardi-Goutieres syndrome , Idiopathic hypereosinophilic syndrome , Vasculitis, Hashimoto’s encephalopathy
Sexual No underlying causes
Trauma Concussion
Urologic No underlying causes
Dental No underlying causes
Miscellaneous No underlying causes

Causes in Alphabetical Order


References

  1. Tolmie JL, Shillito P, Hughes-Benzie R, Stephenson JB (1995). “The Aicardi-Goutières syndrome (familial, early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis)”. J. Med. Genet. 32 (11): 881–4. PMC 1051740. PMID 8592332. Unknown parameter |month= ignored (help)
  2. http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=37301
  3. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1023569/
  4. http://www.ndif.org/public/terms/3
  5. http://www.orpha.net/consor/cgi-
  6. Terwiel E, Hanrahan R, Lueck C, D’Rozario J (2010). “Reversible posterior encephalopathy syndrome associated with bortezomib”. Intern Med J. 40 (1): 69–71. doi:10.1111/j.1445-5994.2009.02097.x. PMID 20561367. Unknown parameter |month= ignored (help)
  7. 7.0 7.1 7.2 Aliaga L, Sánchez-Blázquez P, Rodríguez-Granger J, Sampedro A, Orozco M, Pastor J (2009). “Mediterranean spotted fever with encephalitis”. J. Med. Microbiol. 58 (Pt 4): 521–5. doi:10.1099/jmm.0.004465-0. PMID 19273650. Unknown parameter |month= ignored (help)
  8. http://www.ncbi.nlm.nih.gov/pmc/a
  9. http://www.ncbi.nlm.nih.gov/pmc/a
  10. http://www.ncbi.nlm.nih.gov/pmc/a
  11. http://ghr.nlm.nih.gov/condition/primary-carnitine-
  12. Lin CJ, Chen SP, Wang SJ, Fuh JL (2011). “Cefepime-related encephalopathy in peritoneal dialysis patients”. J Chin Med Assoc. 74 (2): 87–90. doi:10.1016/j.jcma.2011.01.017. PMID 21354086. Unknown parameter |month= ignored (help)
  13. Van Maldergem L, Trijbels F, DiMauro S; et al. (2002). “Coenzyme Q-responsive Leigh’s encephalopathy in two sisters”. Ann. Neurol. 52 (6): 750–4. doi:10.1002/ana.10371. PMID 12447928. Unknown parameter |month= ignored (help)
  14. Arakawa C, Endo A, Kohira R; et al. (2012). “Liver-specific mitochondrial respiratory chain complex I deficiency in fatal influenza encephalopathy”. Brain Dev. 34 (2): 115–7. doi:10.1016/j.braindev.2011.03.002. PMID 21441007. Unknown parameter |month= ignored (help)
  15. Hayasaka K, Brown GK, Danks DM, Droste M, Kadenbach B (1989). “Cytochrome c oxidase deficiency in subacute necrotizing encephalopathy (Leigh syndrome)”. J. Inherit. Metab. Dis. 12 (3): 247–56. PMID 2559245.
  16. Lombroso CT (1990). “Early myoclonic encephalopathy, early infantile epileptic encephalopathy, and benign and severe infantile myoclonic epilepsies: a critical review and personal contributions”. J Clin Neurophysiol. 7 (3): 380–408. PMID 2120281. Unknown parameter |month= ignored (help)
  17. http://www.ncbi.nlm.nih.gov/pmc/a
  18. del Río Fernández M, Plagaro Cordero ME, de Frutos Arribas JF, Bellido Casado J, Velicia Llanes R (1997). “[Hepatic encephalopathy related to omeprazole]”. Rev Esp Enferm Dig (in Spanish; Castilian). 89 (7): 574–5. PMID 9303628. Unknown parameter |month= ignored (help)
  19. http://www.checkorphan.org/research/view/granulomatou
  20. Aledo R, Mir C, Dalton RN; et al. (2006). “Refining the diagnosis of mitochondrial HMG-CoA synthase deficiency”. J. Inherit. Metab. Dis. 29 (1): 207–11. doi:10.1007/s10545-006-0214-2. PMID 16601895. Unknown parameter |month= ignored (help)
  21. Brzosko M, Fiedorowicz-Fabrycy I, Honczarenko K (1996). “[Encephalopathy in the course of idiopathic hypereosinophilic syndrome — clinical-morphological correlations]”. Neurol. Neurochir. Pol. (in Polish). 30 (3): 475–80. PMID 8965982.
  22. Sweiss KI, Beri R, Shord SS (2008). “Encephalopathy after high-dose Ifosfamide: a retrospective cohort study and review of the literature”. Drug Saf. 31 (11): 989–96. PMID 18840018.
  23. Yagupsky P, Wolach B (1993). “Fatal Israeli spotted fever in children”. Clin. Infect. Dis. 17 (5): 850–3. PMID 8286624. Unknown parameter |month= ignored (help)
  24. http://www.ncbi.nlm.nih.gov/pmc/a
  25. Smith MC, Hoeppner TJ (2003). “Epileptic encephalopathy of late childhood: Landau-Kleffner syndrome and the syndrome of continuous spikes and waves during slow-wave sleep”. J Clin Neurophysiol. 20 (6): 462–72. PMID 14734935.
  26. Kumar S, Jain S, Aggarwal CS, Ahuja GK (1987). “Encephalopathy due to inorganic lead exposure in an adult”. Jpn. J. Med. 26 (2): 253–4. PMID 3626166. Unknown parameter |month= ignored (help)
  27. Markand ON (2003). “Lennox-Gastaut syndrome (childhood epileptic encephalopathy)”. J Clin Neurophysiol. 20 (6): 426–41. PMID 14734932.
  28. Coban S, Ceydilek B, Ekiz F, Erden E, Soykan I (2005). “Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection”. Ann Pharmacother. 39 (10): 1737–40. doi:10.1345/aph.1G111. PMID 16105873. Unknown parameter |month= ignored (help)
  29. Kaplan RF, Jones-Woodward L (1997). “Lyme encephalopathy: a neuropsychological perspective”. Semin Neurol. 17 (1): 31–7. doi:10.1055/s-2008-1040910. PMID 9166957. Unknown parameter |month= ignored (help)
  30. Pepin J, Milord F, Guern C, Mpia B, Ethier L, Mansinsa D (1989). “Trial of prednisolone for prevention of melarsoprol-induced encephalopathy in gambiense sleeping sickness”. Lancet. 1 (8649): 1246–50. PMID 2566790. Unknown parameter |month= ignored (help)
  31. Sproule DM, Kaufmann P (2008). “Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome”. Ann. N. Y. Acad. Sci. 1142: 133–58. doi:10.1196/annals.1444.011. PMID 18990125. Unknown parameter |month= ignored (help)
  32. Chang YL, Yang CC, Deng JF; et al. (1999). “Diverse manifestations of oral methylene chloride poisoning: report of 6 cases”. J. Toxicol. Clin. Toxicol. 37 (4): 497–504. PMID 10465248.
  33. Seok JI, Yi H, Song YM, Lee WY (2003). “Metronidazole-induced encephalopathy and inferior olivary hypertrophy: lesion analysis with diffusion-weighted imaging and apparent diffusion coefficient maps”. Arch. Neurol. 60 (12): 1796–800. doi:10.1001/archneur.60.12.1796. PMID 14676060. Unknown parameter |month= ignored (help)
  34. Chiba S (1977). “[Mosse’s syndrome (polycythemia rubra vera)]”. Nippon Rinsho (in Japanese). 35 Suppl 1: 952–3. PMID 613068.
  35. Bogousslavsky J, Regli F, Doret AM; et al. (1983). “Encephalopathy, peripheral neuropathy, dysautonomia, myasthenia gravis, malignant thymoma, and antiacetylcholine receptor antibodies in the CSF”. Eur. Neurol. 22 (5): 301–6. PMID 6628458.
  36. Holliday PL, Climie AR, Gilroy J, Mahmud MZ (1983). “Mitochondrial myopathy and encephalopathy: three cases–a deficiency of NADH-CoQ dehydrogenase?”. Neurology. 33 (12): 1619–22. PMID 6417559. Unknown parameter |month= ignored (help)
  37. Janati A, Erba G (1982). “Electroencephalographic correlates of near-drowning encephalopathy in children”. Electroencephalogr Clin Neurophysiol. 53 (2): 182–91. PMID 6174290. Unknown parameter |month= ignored (help)
  38. Knezević-Pogancev M (2008). “[Ohtahara syndrome–early infantile epileptic encephalopathy]”. Med. Pregl. 61 (11–12): 581–5. PMID 19368276.
  39. D’Arrigo S, Grazia BM, Faravelli F, Riva D, Pantaleoni C (2005). “Progressive encephalopathy with edema, hypsarrhythmia, and optic nerve atrophy (PEHO)-like syndrome: what diagnostic characteristics are defining?”. J. Child Neurol. 20 (5): 454–6. PMID 15968934. Unknown parameter |month= ignored (help)
  40. http://www.in.gov/isdh/23877.htm
  41. http://ghr.nlm.nih.gov/condition/pyridoxal-5-phosphate-
  42. Lukiw WJ, Cho HJ, Kaufmann JC, Crapper McLachlan DR (1990). “The molecular mechanisms of scrapie encephalopathy and relevance to human neurodegenerative disease”. Can. J. Vet. Res. 54 (1): 49–57. PMC 1255606. PMID 2407330. Unknown parameter |month= ignored (help)
  43. 43.0 43.1 Latour P, Biraben A, Polard E; et al. (2004). “Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?”. Hum Psychopharmacol. 19 (3): 193–203. doi:10.1002/hup.575. PMID 15079854. Unknown parameter |month= ignored (help)
  44. Nishizawa M (2005). “[Acute encephalopathy after ingestion of “sugihiratake” mushroom]”. Rinsho Shinkeigaku (in Japanese). 45 (11): 818–20. PMID 16447734. Unknown parameter |month= ignored (help)
  45. http://www.ncbi.nlm.nih.gov/pmc/a
  46. Kalra V, Gulati S, Pandey RM, Menon S (2001). “West syndrome and other infantile epileptic encephalopathies–Indian hospital experience”. Brain Dev. 23 (7): 593–602. PMID 11701262. Unknown parameter |month= ignored (help)

Template:WH Template:WS

Differential Diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Encephalopathy can present in many ways mimicking many other brain conditions. Certain conditions like encephalitis, meningitis, brain tumors, epilepsy, and overdosing of certain medications may mimic encephalopathy.

Differentiating from other symptoms

The symptoms of encephalopathy may overlap with the symptoms of other diseases:

  • Intracranial lesions like tumors, masses, granulomas which are differentiated by the presence of focal neurologic signs and symptoms

Encephalopathy must be differentiated from other causes of headache,seizures and loss of consciousness.

Diseases Symptoms Physical Examination Past medical history Diagnostic tests Other Findings
Headache LOC Motor weakness Abnormal sensory Motor Deficit Sensory deficit Speech difficulty Gait abnormality Cranial nerves CT /MRI CSF Findings Gold standard test
Meningitis + + + History of fever and malaise Leukocytes,

Protein

↓ Glucose

CSF analysis[1] Fever, neck

rigidity

Encephalitis + + +/- +/- + +/- + History of fever and malaise + Leukocytes, ↓ Glucose CSF PCR Fever, seizures, focal neurologic abnormalities
Brain tumor[2] + + + + + Weight loss, fatigue + Cancer cells[3] MRI Cachexia, gradual progression of symptoms
Hemorrhagic stroke + + + + + + + + Hypertension + CT scan without contrast[4][5] Neck stiffness
Subdural hemorrhage + + + + + + Trauma, fall + Xanthochromia[6] CT scan without contrast[4][5] Confusion, dizziness, nausea, vomiting
Neurosyphilis[7][8] + + + + + + STIs + Leukocytes and protein CSF VDRL-specifc

CSF FTA-Ab -sensitive[9]

Blindness, confusion, depression,

Abnormal gait

Complex or atypical migraine + + + + Family history of migraine Clinical assesment Presence of aura, nausea, vomiting
Hypertensive encephalopathy + + + + Hypertension + Clinical assesment Delirium, cortical blindness, cerebral edema, seizure
Wernicke’s encephalopathy + + + + + History of alcohal abuse Clinical assesment and lab findings Ophthalmoplegia, confusion
CNS abscess + + + + + History of drug abuse, endocarditis, immunosupression + leukocytes, glucose and protien MRI is more sensitive and specific High grade fever, fatigue,nausea, vomiting
Drug toxicity + + + + + Drug screen test Lithium, Sedatives, phenytoin, carbamazepine
Conversion disorder + + + + + + + + History of emotional stress Diagnosis of exclusion Tremors, blindness, difficulty swallowing
Metabolic disturbances (electrolyte imbalance, hypoglycemia) + + + + + + Hypoglycemia, hypo and hypernatremia, hypo and hyperkalemia Depends on the cause Confusion, seizure, palpitations, sweating, dizziness, hypoglycemia
Multiple sclerosis exacerbation + + + + + + History of relapses and remissions + CSF IgG levels

(monoclonal bands)

Clinical assesment and MRI [10] Blurry vision, urinary incontinence, fatigue
Seizure + + + + + Previous history of seizures Mass lesion Clinical assesment and EEG [11] Confusion, apathy, irritability,

Other differentials

Toxic encephalopathy must also be differentiated from other diseases that cause personality changes, altered level of consciousness and hand tremors (asterixis). The differentials include the following:[12][13][14][15][16][17][18][19][20][21][22]

Diseases History and Symptoms Physical Examination Laboratory Findings
Personality changes Altered level of consciousness Hand tremors (asterixis) Slurred speech Writing disturbances Voice monotonous Impaired memory Elevated blood ammonia Hyponatremia hypokalemia
Hepatic encephalopathy ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
Alcohol intoxication + + -/+ ++ + + -/+ -/+
Alcohol withdrawal + + ++ + + -/+ -/+
Uremia ++ ++ + -/+ -/+ -/+ ++ Hyperkalemia
Wernicke encephalopathy + + -/+ + + + ++
Toxic encephalopathy from drugs + + -/+ -/+ + -/+ + + -/+ -/+
Altered intracranial pressure + -/+ -/+ -/+ -/+
Intoxication by chemical agents -/+ -/+ -/+ -/+ -/+ -/+ -/+
Malnutrition -/+ -/+ -/+ -/+ -/+
Hypoxic brain injury -/+ -/+ -/+ -/+ -/+
Meningitis and encephalitis -/+ -/+ -/+ + -/+
Hypoglycemia -/+ -/+ -/+ -/+ -/+ -/+

References

  1. Carbonnelle E (2009). “[Laboratory diagnosis of bacterial meningitis: usefulness of various tests for the determination of the etiological agent]”. Med Mal Infect. 39 (7–8): 581–605. doi:10.1016/j.medmal.2009.02.017. PMID 19398286.
  2. Morgenstern LB, Frankowski RF (1999). “Brain tumor masquerading as stroke”. J Neurooncol. 44 (1): 47–52. PMID 10582668.
  3. Weston CL, Glantz MJ, Connor JR (2011). “Detection of cancer cells in the cerebrospinal fluid: current methods and future directions”. Fluids Barriers CNS. 8 (1): 14. doi:10.1186/2045-8118-8-14. PMC 3059292. PMID 21371327.
  4. 4.0 4.1 Birenbaum D, Bancroft LW, Felsberg GJ (2011). “Imaging in acute stroke”. West J Emerg Med. 12 (1): 67–76. PMC 3088377. PMID 21694755.
  5. 5.0 5.1 DeLaPaz RL, Wippold FJ, Cornelius RS, Amin-Hanjani S, Angtuaco EJ, Broderick DF; et al. (2011). “ACR Appropriateness Criteria® on cerebrovascular disease”. J Am Coll Radiol. 8 (8): 532–8. doi:10.1016/j.jacr.2011.05.010. PMID 21807345.
  6. Lee MC, Heaney LM, Jacobson RL, Klassen AC (1975). “Cerebrospinal fluid in cerebral hemorrhage and infarction”. Stroke. 6 (6): 638–41. PMID 1198628.
  7. Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG; et al. (2012). “Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients”. J Neurol Sci. 317 (1–2): 35–9. doi:10.1016/j.jns.2012.03.003. PMID 22482824.
  8. Berger JR, Dean D (2014). “Neurosyphilis”. Handb Clin Neurol. 121: 1461–72. doi:10.1016/B978-0-7020-4088-7.00098-5. PMID 24365430.
  9. Ho EL, Marra CM (2012). “Treponemal tests for neurosyphilis–less accurate than what we thought?”. Sex Transm Dis. 39 (4): 298–9. doi:10.1097/OLQ.0b013e31824ee574. PMC 3746559. PMID 22421697.
  10. Giang DW, Grow VM, Mooney C, Mushlin AI, Goodman AD, Mattson DH; et al. (1994). “Clinical diagnosis of multiple sclerosis. The impact of magnetic resonance imaging and ancillary testing. Rochester-Toronto Magnetic Resonance Study Group”. Arch Neurol. 51 (1): 61–6. PMID 8274111.
  11. Manford M (2001). “Assessment and investigation of possible epileptic seizures”. J Neurol Neurosurg Psychiatry. 70 Suppl 2: II3–8. PMC 1765557. PMID 11385043.
  12. Meparidze MM, Kodua TE, Lashkhi KS (2010). “[Speech impairment predisposes to cognitive deterioration in hepatic encephalopathy]”. Georgian Med News (181): 43–9. PMID 20495225.
  13. Kattimani S, Bharadwaj B (2013). “Clinical management of alcohol withdrawal: A systematic review”. Ind Psychiatry J. 22 (2): 100–8. doi:10.4103/0972-6748.132914. PMC 4085800. PMID 25013309.
  14. Roldán J, Frauca C, Dueñas A (2003). “[Alcohol intoxication]”. An Sist Sanit Navar. 26 Suppl 1: 129–39. PMID 12813481.
  15. Seifter JL, Samuels MA (2011). “Uremic encephalopathy and other brain disorders associated with renal failure”. Semin Neurol. 31 (2): 139–43. doi:10.1055/s-0031-1277984. PMID 21590619.
  16. Handler CE, Perkin GD (1983). “Wernicke’s encephalopathy”. J R Soc Med. 76 (5): 339–42. PMC 1439130. PMID 6864698.
  17. Kim Y, Kim JW (2012). “Toxic encephalopathy”. Saf Health Work. 3 (4): 243–56. doi:10.5491/SHAW.2012.3.4.243. PMC 3521923. PMID 23251840.
  18. Hartmann A, Buttinger C, Rommel T, Czernicki Z, Trtinjiak F (1989). “Alteration of intracranial pressure, cerebral blood flow, autoregulation and carbondioxide-reactivity by hypotensive agents in baboons with intracranial hypertension”. Neurochirurgia (Stuttg). 32 (2): 37–43. doi:10.1055/s-2008-1053998. PMID 2497395.
  19. Kumar N (2011). “Acute and subacute encephalopathies: deficiency states (nutritional)”. Semin Neurol. 31 (2): 169–83. doi:10.1055/s-0031-1277986. PMID 21590622.
  20. Chiu GS, Chatterjee D, Darmody PT, Walsh JP, Meling DD, Johnson RW; et al. (2012). “Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1”. J Neurosci. 32 (40): 13945–55. doi:10.1523/JNEUROSCI.0704-12.2012. PMC 3476834. PMID 23035103.
  21. Peate I (2004). “An overview of meningitis: signs, symptoms, treatment and support”. Br J Nurs. 13 (13): 796–801. doi:10.12968/bjon.2004.13.13.13501. PMID 15284663.
  22. Abdelhafiz AH, Rodríguez-Mañas L, Morley JE, Sinclair AJ (2015). “Hypoglycemia in older people – a less well recognized risk factor for frailty”. Aging Dis. 6 (2): 156–67. doi:10.14336/AD.2014.0330. PMC 4365959. PMID 25821643.

Template:WH Template:WS

Risk Factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Elderly patients and patients with multisystem disease are at risk for the development of encephalopathy.

Risk Factors

Most common cause of encephalopathy is metabolic cause. In this condition there will be increase in toxic substance to brain keeping the person at high risk of encephalopathy.

Common

Less common

PRECIPITATING FACTORS FOR ENCEPHALOPATHY
Underlying Disease Examples Precipitating Factors
LIVER DISEASES Cirrhosis, Acute Liver Failure, Budd Chiari Syndrome, Hepatoma Dehydration, Infection, Constipation, GI Bleeding, Electrolyte Imbalance
RENAL DISEASES Renal Failure, Hyponatremia Electrolyte Imbalance, Uremia, Dialysis, Uncontrolled HTN, Thiamine Deficiency
DIABETES DKA Chronic hyperglycemia, Stress, Trauma, Infection, SGLT-2 inhibitors, Thiazide Diuretics, Acute pancreatitis
STROKE, EPILEPSY Ischemic stroke, Status Epilepticus Acute seizure, Acute stroke

References

[1] [2] “Metabolic encephalopathy secondary to diabetic ketoacidosis: a case report | BMC Endocrine Disorders | Full Text”. [3]Template:WH Template:WS

Natural History, Complications and Prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2]

Overview

Encephalopathies of different types have different ways of progression of disease. Few conditions can lead to abrupt onset and few develop over a period of time. Some types are completely reversible where as few cause irreversible damage and dysfunction. Most encephalopathies have similar kind of progression with little variation.

Natural History

Patients presenting with encephalopathy usually have past history of any chronic disease. In various conditions, some precipitating factors may contribute to the manifestation of encephalopathy such as constipation or infection in patients with liver disease. Symptoms are quite varied among the different types of encephalopathies. They can be ranging from sub-clinical presentation to coma. Encephalopathies are the presentation of severe disease which if untreated never resolves on its own. Prompt identification and treatment are warranted in these conditions, if delayed chances of residual neurological effects are more.

Complications

Complications related to encephalopathy are due to the underlying disease process such as electrolyte imbalances, drugs and poisons, sepsis and multiorgan failure and can include:

Prognosis

Treating the underlying cause of the disorder may improve or reverse symptoms. However, in some cases, the encephalopathy may cause permanent structural changes and irreversible damage to the brain. Some encephalopathies can be fatal. Certain factors are of prognostic importance like:

  • Age
  • Rapidity of onset
  • Delay in correcting the cause
  • Most important is the underlying cause

References

Template:WH

Template:WS

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | ECG | EEG | Chest X Ray |CT | MRI | Echocardiography or Ultrasound |Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical therapy | Surgery | Prevention | Cost-effectiveness of Therapy| Future or Investigational Therapies

See also

See also

Template:CNS diseases of the nervous system



Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH